Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Decitabine × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

peginterferon alfa-2b 1 Zidovudine 1 Valproic Acid 1 Interferon alpha-2 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03558412 2018-09-14

A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma

Zhengzhou University

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡